KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI.

J Clin Med · 2025 · PMC12653615 · PMID 41303148

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

did not reach statistical significancep = 0.068so close (0.05 < p ≤ 0.1)

In the same way, PFS curves ( Figure 2 ) demonstrated earlier disease progression in unfavorable KELIM patients but did not reach statistical significance ( p = 0.068). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.